The Maharashtra State Consumer Disputes Redressal Commission delivered a significant ruling in a case involving arbitrary rejection of a medical insurance claim and unilateral cancellation of a policy. The Commission held that the insurance company's reliance on a non-material disclosure - childhood speech delay - to repudiate a claim for Burkitt's Lymphoma and fungal infection was legally untenable, constituting deficiency in service and unfair trade practice. The complainant was awarded Rs. 20,00,000 under the policy cap, along with compensation and litigation costs, setting a precedent for the interpretation of material disclosure in insurance contracts.
Background & Facts
The Dispute
The complainant, Dr. Amol Ingule, purchased a medical insurance policy (OPTIMA RESTORE FLOATER, Policy No. 160101/11121/A) from Apollo Munich Health Insurance Co. Ltd. for a sum insured of Rs. 20,00,000, covering the period from 21st February 2017 to 20th February 2018. In April 2017, the complainant's son was diagnosed with Burkitt's Lymphoma (blood cancer) and underwent emergency surgery at Apollo Hospital, Navi Mumbai. The complainant filed a claim for reimbursement of medical expenses, which the insurance company rejected on 27th May 2017, citing non-disclosure of a childhood speech delay as a pre-existing condition. The complainant contested this rejection, arguing that speech delay was not a disease or medical condition and had no correlation with the subsequent cancer diagnosis.
Key Facts
- 21.02.2017: Complainant purchased the insurance policy for Rs. 20,00,000
- 17.04.2017: Complainant's son hospitalized for severe stomach ache
- 18.04.2017: Emergency surgery performed; diagnosis of Burkitt's Lymphoma
- 27.05.2017: Insurance company rejected the claim via email, citing non-disclosure of speech delay
- 31.05.2017: Complainant responded, clarifying that speech delay was not a medical condition
- April-May 2017: Son diagnosed with Burkitt's Lymphoma
- November-December 2017: Son developed fungal infection post-chemotherapy; underwent brain surgeries at Tata Memorial Hospital
- 23.12.2017 - 05.02.2018: Son hospitalized at Apollo Hospital, Navi Mumbai; passed away in February 2018
- Total medical expenditure: Rs. 33,58,794 incurred across Apollo Hospital and Tata Memorial Hospital
- Policy cancellation: Insurance company unilaterally cancelled the policy and forfeited the premium
Procedural History
- 2018: Consumer complaint filed before Maharashtra State Consumer Disputes Redressal Commission (Complaint No. SC/27/CC/866/2018)
- 13.10.2021: Opposite Parties failed to file Written Version; "No Written Version" order passed
- 04.07.2025: Final opportunity granted to Opposite Parties to file written notes on legal points; they failed to comply
- 17.06.2026: Final hearing conducted; judgment reserved
- 02.07.2026: Judgment delivered
The Parties' Positions
Complainant
- Argued that the rejection of the claim and cancellation of the policy were arbitrary and based on a non-material disclosure (speech delay)
- Contended that speech delay was not a disease or medical condition and had no nexus with the subsequent cancer diagnosis
- Submitted that the insurance company acted in bad faith to avoid its contractual liability
- Provided medical records, bills, and evidence of expenditure totaling Rs. 33,58,794
Opposite Parties
- Failed to file a Written Version or contest the complainant's evidence
- Did not appear to argue their case despite multiple opportunities
Relief Sought
The complainant sought:
- Reimbursement of medical expenses up to the policy limit of Rs. 20,00,000
- Compensation for mental agony, emotional trauma, and financial hardship
- Costs of litigation
- Interest on the awarded amount from the date of repudiation
The Legal Issue
The central questions before the Commission were:
- Whether the insurance company's rejection of the claim and unilateral cancellation of the policy based on non-disclosure of a childhood speech delay constituted deficiency in service and unfair trade practice under the Consumer Protection Act, 1986?
- Whether the complainant was entitled to reimbursement of medical expenses, and if so, to what extent given the policy's sum insured cap?
Arguments Presented
For the Complainant
- Relied on the principle of utmost good faith in insurance contracts, arguing that the disclosure of speech delay was immaterial and irrelevant to the subsequent medical condition
- Contended that the insurance company's actions were arbitrary, malicious, and designed to defeat genuine claims
- Submitted that the policy cap of Rs. 20,00,000 should be honored as the contract was illegally terminated
- Argued that the mental agony and financial hardship endured by the complainant warranted compensation
For the Opposite Parties
The Opposite Parties did not present any arguments or file a Written Version.
The Court's Analysis
The Commission conducted a thorough analysis of the evidence and legal principles governing insurance contracts and consumer protection:
"The grounds on which the Insurance Company repudiated the Complainant's initial claim and unilaterally terminated the medical policy are completely arbitrary, legally untenable, and malicious. The Opposite Parties have placed primary reliance on the non-disclosure of a temporary 'speech delay' in the child's early developmental years to claim a breach of the utmost good faith doctrine. However, a developmental speech delay in a growing child is an ordinary physiological milestone variance; it is neither a chronic disease, a pre-existing medical deformity, nor a material fact that a reasonable person would deem necessary to declare under a standard health proposal form."
The Commission emphasized the lack of nexus between the disclosed speech delay and the subsequent diagnosis of Burkitt's Lymphoma and fungal infection, which were the actual causes of hospitalization and medical expenditure. It held that the insurance company's reliance on such a non-material disclosure to repudiate the claim was unfair and unreasonable.
"More crucially, from a medical and clinical standpoint, there is absolutely zero nexus, correlation, or pathological link between a childhood speech delay and the subsequent, aggressive onset of Burkitt's Lymphoma (blood cancer) or the fatal brain fungal infection that followed. For an insurance company to leverage a minor, outgrown childhood milestone to escape its multi-lakh contractual liability during a family's gravest hour of medical crisis is a textbook example of an unfair trade practice."
The Commission also criticized the unilateral cancellation of the policy and forfeiture of the premium, which deprived the complainant of his financial safety net during a medical emergency. Since the Opposite Parties failed to contest the complainant's evidence, the Commission accepted the complainant's version as unchallenged and conclusive.
Regarding the quantum of reimbursement, the Commission noted that while the complainant had incurred expenses of Rs. 33,58,794, the policy explicitly capped the insurer's liability at Rs. 20,00,000. The Commission held that it could not rewrite the contract to exceed this limit, despite its sympathy for the complainant's plight.
The Verdict
The Commission partly allowed the complaint and passed the following orders:
- The Opposite Parties (Apollo Munich Health Insurance Co. Ltd.) were jointly and severally directed to pay Rs. 20,00,000 to the complainant under Policy No. 160101/11121/A, representing the maximum sum insured.
- The Opposite Parties were directed to pay interest at 9% per annum on Rs. 20,00,000 from the date of repudiation/termination (27th May 2017) until the date of realization.
- The Opposite Parties were directed to pay Rs. 20,000 as compensation for mental agony, emotional trauma, and financial hardship.
- The Opposite Parties were directed to pay Rs. 25,000 as litigation costs.
- The Opposite Parties were ordered to comply with the judgment within 30 days of receiving a certified copy, failing which the interest rate would increase to 10% per annum on the principal amount.
What This Means For Similar Cases
Material Disclosure in Insurance Contracts
- Non-material disclosures cannot justify claim rejection: Insurance companies cannot repudiate claims based on disclosures that are not medically relevant or have no nexus with the subsequent medical condition. Developmental milestones like speech delay, which are temporary and non-pathological, do not qualify as material facts requiring disclosure.
- Utmost good faith requires reasonableness: The doctrine of uberrimae fidei (utmost good faith) obligates both parties to act reasonably. Insurers must demonstrate a clear and direct link between the disclosed information and the claimed medical condition before rejecting a claim.
Policy Cancellation and Forfeiture of Premium
- Unilateral cancellation is impermissible: Insurers cannot cancel policies mid-term based on arbitrary or unsustainable grounds. Such actions constitute deficiency in service and unfair trade practice under the Consumer Protection Act, 1986.
- Forfeiture of premium is illegal: If a policy is cancelled without valid justification, insurers must refund the premium to avoid unjust enrichment. Forfeiture of premium in such cases is legally untenable.
Quantum of Reimbursement and Interest
- Policy cap is sacrosanct: Courts cannot rewrite insurance contracts to exceed the sum insured agreed upon by the parties. Complainants are entitled to reimbursement only up to the policy limit, even if actual expenses exceed this amount.
- Interest as a deterrent: Awarding pendente lite and future interest (e.g., 9% per annum) serves as a deterrent against delayed settlements and compensates for financial erosion. Failure to comply with the judgment within the stipulated timeline may result in higher interest rates (e.g., 10% per annum).
Compensation for Mental Agony and Litigation Costs
- Compensation for emotional trauma: Consumer forums can award compensation for mental agony, emotional trauma, and financial hardship caused by deficient service. This serves as a punitive measure against unfair trade practices.
- Litigation costs as a deterrent: Awarding litigation costs discourages frivolous defenses and ensures that complainants are not financially burdened by pursuing legitimate claims.
